How has the pandemic affected rural and urban cancer patients?February 18, 2021Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Checkpoint inhibitors’ ‘big picture’ safety shown with preexisting autoimmune diseasesFebruary 16, 2021MelanomaOncology
FDA approves first drug that protects against chemo-induced myelosuppressionFebruary 16, 2021Lung CancerOncology
CCR score can guide treatment decisions after radiation in prostate cancerFebruary 13, 2021Genitourinary CancerProstate CancerOncology
Liquid vs. tissue biopsy in advanced prostate cancer: Why not both?February 12, 2021Genitourinary CancerOncology
Declines in PSA screening may account for rise in metastatic prostate cancersFebruary 12, 2021Genitourinary CancerOncologyProstate Cancer
‘Unprecedented’ long-term survival after immunotherapy in pretreated NSCLCFebruary 11, 2021Lung CancerOncology
Cisplatin tops cetuximab for advanced head and neck cancerFebruary 9, 2021Head & Neck/Thyroid CancersOncology
Neoadjuvant atezolizumab safe for patients with resectable lung cancerFebruary 9, 2021Lung CancerOncology
Managing cancer outpatients during the pandemic: Tips from MSKCCFebruary 8, 2021Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanomaOncology
